HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms
Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the closing of its license agreements with the …
MSIP Recognizes Researchers and i3 Funding Awardees at Annual Innovation Awards Ceremony
The annual Mount Sinai Innovation Awards Ceremony took place on November 6. A hybrid event, the ceremony honored researchers from across the System for various achievements and included awards presented by MSIP: Inventor of the Year and Transaction of the Year. MSIP …
Nina Bhardwaj, MD, Discusses her Cancer Vaccine Research with MSIP
Meet Nina Bhardwaj, MD, PhD, Professor of Medicine (Hematology and Medical Oncology) and Urology, and Medical Director of the Vaccine and Cell Therapy Laboratory (VCTL) at the Icahn School of Medicine at Mount Sinai. Dr. Bhardwaj and her team are conducting groundbreaking …
Icahn School of Medicine at Mount Sinai Licenses Next-Generation Diagnostic Test Epigenetic /AI Platform to GNOMX Corp.
The Icahn School of Medicine at Mount Sinai has agreed to an exclusive license option with GNOMX Corp. (GNOMX) for epigenetic diagnostic and prognostic technology for infectious diseases. This groundbreaking patent-pending technology was developed by collaborating researchers at Icahn Mount Sinai, Princeton …
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission
The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine. The phase …
BeeKeeperAI Raises $12.1 Million Series A to Accelerate AI Development on Privacy Protected Healthcare Data
BeeKeeperAI, Inc., a pioneer in zero-trust, collaboration software for the development and deployment of artificial intelligence (AI), today announced that it has closed $12.1 million in Series A financing. The round was led by Sante Ventures, with participation from the Icahn School …
Meet the Finalists for the Mount Sinai Pitch Challenge 2023
Get to know the teams competing in this year’s Mount Sinai Pitch Challenge on May 4, the final event in MSIP’s Entrepreneurship Program, as they present healthcare solutions with commercial and business potential for a chance to win a $25,000 cash prize! …
Elementa Labs: 2022 in Review
Take a look at the exciting updates from the past year of Elementa Labs! In 2022, MSIP witnessed the growth of several Elementa portfolio companies from its first two cohorts: the inaugural Fall 2021 and Spring 2022. These companies have continued to …
Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease
Risk scoring by KidneyIntelX resulted in a 4.5-fold increase in new drug prescriptions (for SGLT2 inhibitors) for high risk compared to low risk patients, an observed reduction of HbA1c levels in the highest risk patients, an overall increased use of antihypertensive therapeutics, …